An abstract on Imugene Ltd (ASX:IMU, OTC:IUGNF)'s allogeneic CD19 CAR-T candidate azer-cel has been accepted for an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition, running December 6-9, 2025, in Orlando, Florida.
The abstract, titled “Azer-cel, an allogeneic (allo) CD19 CAR T, in combination with low-dose interleukin-2 (IL-2) demonstrates clinical activity in patients with large B-cell lymphoma (LBCL) who relapsed after autologous (auto) CAR T”, will be delivered in the session “Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Next Generation CAR-T Clinical Trials in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma and Multiple Myeloma.”
European Lithium Ltd (ASX:EUR, OTCQB:EULIF)’s September 2025 quarter was dominated by step-ups at the Tanbreez rare earths project in Greenland, portfolio reshaping through share sales in NASDAQ-listed Critical Metals Corp (CRML), and steady de-risking across its European lithium footprint.
On the ground in Greenland, the company reported a stream of strong assays. Historic 2010 core from the Hill deposit averaged 0.58% TREO with 24.9% heavy rare earths (HREO) and 112 parts per million (ppm) gallium oxide across 10 diamond holes — higher than previously expected — while new 2024 drilling at the Fjord area returned 0.48–0.55% TREO with ~27% HREO (holes A2-24 to C-24), followed by consistent 0.40–0.42% TREO with ~26% HREO (holes D-24 to F-24).
FuboTV Inc (NYSE: FUBO) on Monday reported better than expected financial results for its third quarter 2025, as the sports-centric streaming platform also swung to an adjusted profit for the period.
The company posted a loss of $0.06 per share for the quarter, better than the $0.09 deficit expected by analysts.
Coeur Mining Inc (TSX:CDM) and New Gold Inc. (TSX:NGD) have announced a definitive agreement under which Coeur will acquire all outstanding shares of New Gold in an all-stock transaction valued at approximately $7 billion.
The deal positions the new entity among the top 10 global precious metals producers and top five silver producers, with enhanced market liquidity and potential inclusion in major US indexes, Coeur said in a statement.
SM Energy Company (NYSE: SM) on Monday announced that it will acquire rival Civitas Resources Inc (NYSE: CIVI) in an all-stock transaction valued at about $2.8 billion.
Under the terms of the agreement, Civitas shareholders will receive 1.45 shares of SM Energy for each Civitas share held.
American Resources Corp (NASDAQ:AREC)’s ReElement Technologies subsidiary announced a $1.4 billion joint partnership with the US Department of War's Office of Strategic Capital (OSC).
The company said the funding, which includes two separate loans matched by private capital, supports the expansion of ReElement's partnership with Vulcan Elements and will directly support the production of advanced rare earth element separation, metallization, and magnet manufacturing capabilities in the US.
Ideal Power Inc (NASDAQ:IPWR) has announced the appointment of David Somo as its CEO and president.
Somo, who is also joining the company’s board of directors, brings over 30 years of experience in the semiconductor industry, with leadership roles spanning industrial, automotive, data center, consumer, computing, and communications markets.
Trust Stamp Inc (NASDAQ:IDAI, EURONEXT:AIID) said it is expanding into cryptocurrency and asset tokenization with the launch of its biometrically validated, quantum-secure TSI Wallet, following the company’s recent $10 million capital raise.
The Atlanta-based identity authentication company said the TSI Wallet will function as both a non-custodial digital wallet and a “wallet of wallets,” allowing users to securely store and manage multiple digital assets.
Phunware Inc (NASDAQ:PHUN) has announced the publication of a new white paper outlining strategies for the hospitality industry to increase ancillary revenue and enhance guest experiences through digital engagement.
According to the mobile technology firm, the report identified that 35% of guest spending occurs after check-in, representing a potential $2 million annual revenue opportunity for a 200-room property operating at 60% occupancy.
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF) released an update on its pending acquisition of Challenger Energy announced earlier this year.
The acquisition, which will see Sintana acquire all issued and to-be-issued shares of Challenger, is to be carried out through a court-sanctioned scheme of arrangement under Isle of Man law.
Digi Power X Inc (NASDAQ:DGXX, TSX-V:DGX) announced that it held cash, Bitcoin (BTC), Ethereum (ETH) and cash deposits of about $85 million as of October 31, 2025, up from $29 million in the previous month, significantly strengthening its balance sheet and liquidity position to support its 2026 AI infrastructure development plan.
The plan includes the targeted deployment of high-efficiency Tier III AI data centers and expansion of the company’s critical power capacity across multiple US sites.
First Phosphate Corp. (CSE:PHOS, OTCQX:FRSPF) announced that its common shares have begun trading on the Tradegate Exchange in Germany.
The listing provides European investors with the ability to trade First Phosphate shares during regular and extended EU market hours.
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) announced that it has achieved 23 Exahash per second (EH/s) in global Bitcoin-mining capacity, positioning the company amongst industry leaders in 2025 with 283% year-to-date growth.
The multinational digital infrastructure company also said it has completed its C$2.3 million strategic land acquisition in Grand Falls, New Brunswick, adding 32.5 acres adjacent to the company's existing 6-acre property acquired in April 2021.
Meren Energy Inc (TSX:MER, OTCQX:MRNFF) announced that its common shares have begun trading on the OTCQX Best Market in the US under the ticker symbol “MRNFF.”
The company said its shares will continue to trade on the Toronto Stock Exchange and Nasdaq Stockholm under the symbol “MER.”
Guardian Metal Resources plc (LON:GMET) shares rose 6.6% to 107.65p after the company reported high-grade gold, silver and copper results from its Garfield project in Nevada and announced the appointment of experienced mining executive Michael Schlumpberger to its board.
Recent sampling at the Garfield project’s Power Line zone returned standout assays including gold at 18.3 grammes per tonne, 145 g/t silver, and 14% copper.
Shares in 80 Mile PLC (AIM:80M, OTCQB:BLLYF) rose as much as 12% in early trading after the explorer agreed a $30 million joint venture with USFM Corporation to develop its Disko-Nuussuaq nickel and copper project in Greenland.
Under the binding heads of terms, USFM will fund the investment to earn a 51% stake, while 80 Mile will retain 49% and act as project operator.
Anglo Asian Mining Plc (LSE:AAZ, OTC:AGXKF) has signed a sales agreement with commodities trader Trafigura for copper concentrate produced at its Demirli mine in Karabakh, Azerbaijan.
The deal includes a revolving prepayment facility of up to $25 million, giving the miner access to working capital as production ramps up.
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has completed the first surgical case using its Remplir™ nerve repair device in Hong Kong and formally introduced the product to clinicians at the HKOA 45th Annual Congress.
The Hong Kong case marks the start of clinical use and commercial sales in the market, following regulatory clearance and the appointment of MontsMed as Orthocell’s exclusive in-country distributor. The company said MontsMed will focus on adoption through leading hospitals and specialist surgeons.
Provaris Energy Ltd (ASX:PV1, OTC:GBBLF) strengthened its position in the emerging hydrogen and carbon transport sectors during the September quarter, progressing key partnerships with global players and advancing the commercialisation of its proprietary compressed hydrogen (H₂) and liquid carbon dioxide (LCO₂) technologies.
The company deepened collaboration with major industry players including Japan’s Kawasaki Kisen Kaisha (“K” LINE), Baker Hughes, and Yinson Production AS, while commissioning a new robotics innovation centre in Norway to accelerate prototype fabrication for its compressed hydrogen (H₂) and liquid carbon dioxide (LCO₂) tanks.
Resolution Minerals Ltd (ASX:RML, OTC:RLMLF) has reported a strong September quarter, highlighted by expanded drilling, major funding and strengthened US positioning at its flagship Horse Heaven Gold–Antimony–Tungsten–Silver Project in Idaho.
The company said it made progress across technical, corporate and strategic fronts, advancing Horse Heaven as a district-scale critical minerals project aligned with US national security priorities.
Apollo Minerals Ltd (ASX:AON, OTC:APOMF) has lodged its September 2025 quarterly report, outlining progress across its core Gabonese assets.
At the Salanie Gold Project, the company advanced a diamond drilling campaign targeting untested zones at key prospects and extending previously reported shallow high-grade mineralisation at A1 (11.7 metres at 4.3 g/t Au from 9.6 metres). Phase 2 work at A1 returned 3.8 metres at 1.3 g/t Au from 17.5 metres, with the mineralised trend remaining open to the north.
Riversgold Ltd (ASX:RGL, OTC:RVSGF) has delivered a September quarter highlighted by a full project funding and mining partnership at its flagship Northern Zone Gold Project near Kalgoorlie, a new farm-out in Canada, and a successful $1.8 million placement to support ongoing exploration.
The company finalised a binding Right to Mine and Co-Operation Agreement with MEGA Resources, an established Western Australian mining contractor, to advance Riversgold’s 80%-owned Northern Zone Gold Project (Kalgoorlie East).
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF), a leading developer of a new class of synthetic anti-infectives, has released its Q1 FY2026 results and operational highlights which include:
Patient dosing is underway in Recce’s registrational Phase 3 clinical trial for diabetic foot infections (DFI) in Indonesia, with five clinical sites now active and the study tracking to an interim analysis in Q1 CY2026. Up to 310 patients will be randomised to receive either RECCE® 327 Topical Gel (R327G) or placebo.
archTIS Ltd (ASX:AR9, OTCQB:ARHLF) has released Version 9 (V9) of NC Protect, its data-centric security platform for Microsoft environments, positioning the software for defence, government and other regulated customers.
Key points
archTIS Ltd (ASX:AR9, OTCQB:ARHLF) has released its Quarterly Activities Report for the quarter ended June 30, 2025. The company highlighted a step-change in scale from a US acquisition, expanded US Department of Defense (DoD) work and a strengthened cash position.
Key points
Kairos Minerals Ltd (ASX:KAI, OTCQB:KAIFF) has delivered a pivotal September quarter, finalising a landmark mineral rights deal with lithium major Pilbara Minerals Ltd (ASX:PLS), expanding drilling across its flagship Mt York Gold Project, and completing an oversubscribed A$27 million capital raise to accelerate exploration and feasibility work.
The company secured a Mineral Rights Agreement (MRA) granting Kairos ownership of all mineral rights — except lithium and tantalum — across 367 square kilometres of PLS tenure adjacent to Mt York in the Pilbara.
Elixir Energy Ltd (ASX:EXR, OTC:ELXPF) has appointed Justin Ferravant as chief financial officer and company secretary, replacing Vicky Allinson, who has retired from finance and resigned from the role.
The appointment takes effect immediately and coincides with a period of increased field activity for Elixir, with multiple testing, drilling and seismic programs scheduled over the next six months. The company said the phase marks an inflection point that will emphasise tighter financial control, disciplined capital management and execution across its programs.
Imugene Ltd (ASX:IMU, OTC:IUGNF)’s September quarter was defined by accelerating clinical momentum in its lead CAR-T program, a disciplined portfolio refocus, and a bolstered balance sheet following a successful capital raise and an FY24 R&D tax refund.
Late in the period, the company reported an updated 81% overall response rate in its Phase 1b trial of azer-cel (azercabtagene zapreleucel) for relapsed/refractory DLBCL, with 13 of 16 patients responding, including seven complete responses and six partial responses.
Imugene Ltd (ASX:IMU, OTC:IUGNF) has achieved the first milestone under its licence agreement with Precision BioSciences and will issue 19,491,635 shares along with a US$3 million cash payment. The milestone was triggered as the company began discussions with the US FDA on a potential pivotal trial for azer-cel — the allogeneic CAR T-cell therapy it licensed from Precision in mid-2023.
“This marks an important milestone for Imugene. We look forward to meeting with the FDA in November to obtain guidance on the optimal design and pathway for a Phase 2/3 clinical trial to advance this exciting technology to patients and clinicians,” Imugene’s CEO, Leslie Chong, said. “The clinical data is highly encouraging, and the recent update on patients who have not previously received CAR T therapy further strengthens our confidence in the program."